1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sensient Technologies and its subsidiary Sensient Receivables entered into an amended trade receivables securitization program on August 31, 2026, adding PNC Bank as a purchaser and administrative agent. The facility limit rises from $105 million to $115 million, and the termination date moves to August 30, 2027. The filing describes a financing agreement and does not report any results or changes to earnings.
Facility limit increased from $105 million to $115 million
Termination date extended to August 30, 2027
PNC Bank added as a purchaser and administrative agent; Wells Fargo Bank remains a purchaser
Amendment dated August 31, 2026, filed as Exhibit 10.1
JATT III Acquisition Corp, a blank check company, closed its initial public offering on August 27, 2026, selling 6,900,000 ordinary shares at $10.00 per share for gross proceeds of $69,000,000, including the full exercise of the underwriters' over-allotment option. The company also sold 234,000 private placement shares to its sponsor, JATT Ventures III L.P., for $2,340,000, and placed $69,000,000 in a trust account for public shareholders. The company has 24 months to complete a business combination and has not yet selected a target.
IPO: 6,900,000 ordinary shares at $10.00 per share, gross proceeds of $69,000,000, closed August 27, 2026
Private placement: 234,000 shares to JATT Ventures III L.P. for $2,340,000
Trust account: $69,000,000 ($10.00 per public share) deposited as of August 27, 2026
Completion window: 24 months from the IPO closing; no business combination target selected
VenHub Global disclosed a $100 million equity purchase agreement with Euphoria Capital, under which the company may sell new common stock to the investor at its discretion. The company also reported on September 1, 2026 that Nasdaq notified it that its shares have closed below $1.00 for 30 consecutive business days, so it no longer meets Nasdaq's minimum bid price requirement. The new share sales could dilute existing shareholders, and the Nasdaq notice creates a compliance deadline the company may not meet.
Equity Purchase Agreement with Euphoria Capital allows VenHub to require purchases of up to $100,000,000 of common stock, with the commitment period ending no later than 24 months after August 26, 2026.
VenHub will issue 800,000 Commitment Shares to the investor, and it cannot issue put shares above 18,278,571 until it obtains shareholder approval required by Nasdaq Rule 5635(d).
Nasdaq notice received September 1, 2026 cites a closing bid price below $1.00 for the last 30 consecutive business days.
VenHub has until March 1, 2027 to regain compliance, and the filing says there can be no assurance it will do so.
Fold Holdings notified its investor on August 27, 2026 that it is terminating the Equity Purchase Facility, which had committed up to $250 million in new common stock purchases. No advance notices were outstanding, and the company said it paid no prepayment fees or penalties; it ended the facility to keep the option of alternative financing. The company also said it set October 22, 2026 for a special shareholder meeting on matters in its August 7, 2026 preliminary proxy statement.
Termination takes effect September 3, 2026; no advance notices were outstanding at the time of notice
The facility had a commitment of up to $250 million in newly issued common stock, drawn at the company's discretion
No prepayment fees or penalties were incurred
Special shareholder meeting set for October 22, 2026; record date September 4, 2026
Corvex closed a private placement on September 2, 2026, selling 3,904,970 common shares at $7.75 per share and 353.098 shares of Series D Non-Voting Convertible Preferred Stock at $7,750 per share. The company says the roughly $33 million in gross proceeds will fund expansion of its critical IT power capacity from about 1.5 MW to about 8 MW by year-end 2026, with a right of first refusal on another 12.5 MW. Because the company must file a registration statement for resale of the shares by October 2, 2026, the new shares may later become available for sale in the market.
Common stock sold at $7.75 per share; Series D Preferred sold at $7,750 per share, with closing on September 2, 2026
Press release cites about $33 million in gross proceeds before fees and expenses, and pro forma cash of about $55 million versus $22 million as of June 30, 2026
Goldman Sachs, Morgan Stanley and Oppenheimer are joint lead placement agents; the company agreed to pay placement fees
Resale registration statement due to the SEC by October 2, 2026
VolitionRx entered a waiver and consent with its lender Lind Global Asset Management XII on September 2, 2026. Lind agreed that all at-the-market (ATM) stock sales, including amounts above the $10 million annual cap, count as permitted sales and waived related default and remedy rights tied to those sales. The waiver removes a potential default risk for the company while it sells shares under its ATM program, but it also means share sales above the prior cap can proceed without the lender's objection.
Lind consented to all ATM Agreement sales, including amounts above $10 million in a calendar year, as Permitted ATM Sales.
Lind waived remedies tied to ATM sales under the Purchase Agreement and both Notes, including rights to accelerate amounts due.
Conversion Price of the Notes and Exercise Price of the Warrants were adjusted for ATM sales through August 28, 2026; sales after that date are excluded from adjustment.
The Notes are $7.5 million (May 15, 2025) and $2.4 million (January 7, 2026); the warrants cover 651,042 and 350,018 shares.
Cal-Maine Foods entered a Second Amended and Restated Credit Agreement dated August 31, 2026, with BMO Bank N.A. as administrative agent, providing a senior unsecured revolving credit facility of up to $250 million. As of September 1, 2026, nothing had been borrowed under the facility and $5.9 million in standby letters of credit had been issued, and the facility matures August 31, 2031. The filing does not describe a new borrowing, but it sets the terms under which the company can borrow, including covenants that limit dividends and share repurchases.
Revolver of up to $250 million, with a $25 million sublimit for standby letters of credit and a $25 million sublimit for swingline loans
No amounts borrowed as of September 1, 2026; $5.9 million in standby letters of credit issued
Five-year term maturing August 31, 2031; amends and restates the credit agreement dated November 15, 2021
Covenants include a maximum Total Funded Debt to Capitalization Ratio of 50% tested quarterly and a minimum Tangible Net Worth of $1.5 billion plus 50% of consolidated net income (if positive) less permitted restricted payments
Inflection Point Acquisition Corp. VIII, a blank-check company (SPAC), closed its initial public offering of 28,750,000 units at $10.00 per unit on August 31, 2026, including the full exercise of the underwriters' over-allotment option, for gross proceeds of $287,500,000. Concurrently, the company sold 8,000,000 private placement warrants for $8,000,000, and $287,500,000 of the proceeds was placed in a trust account that generally cannot be released until a business combination is completed or shareholders redeem their shares.
IPO closed August 31, 2026: 28,750,000 units at $10.00 each, $287,500,000 gross proceeds
Private placement: 8,000,000 warrants at $1.00 each for $8,000,000, sold to the sponsor (5,000,000) and Cohen & Company Capital Markets (3,000,000)
Trust account holds $287,500,000, including up to $13,687,500 of the underwriters' deferred discount; annual withdrawals for working capital are limited to $1,000,000
Steven Tannenbaum, William J. Liquori and William Denkin appointed independent directors on August 27, 2026; units began trading as IPHXU on August 28, 2026
Southern Cross Acquisition II Corp., a blank check company, closed its initial public offering on August 27, 2026, selling 7,652,630 units at $10.00 each. The company placed $76,717,616 in a trust account for public shareholders, and its auditor flagged substantial doubt about its ability to continue as a going concern, tied to a 12-month deadline to complete a business combination. The filing states that no target business has been selected.
IPO of 7,652,630 units at $10.00 per unit, generating gross proceeds of $76,526,300, including a partial over-allotment exercise of 152,630 units
Private sale of 224,932 units at $10.00 per unit, generating $2,249,320, to the sponsor and D. Boral Capital LLC
$76,717,616 placed in trust account with Equiniti Trust Company, LLC as trustee
Auditor TAAD, LLP included a going concern paragraph; the company must complete a business combination within 12 months of the IPO closing
NXP B.V., a wholly owned subsidiary of NXP Semiconductors, signed a $250.0 million unsecured senior loan facility with the European Investment Bank on September 1, 2026. Proceeds are expected to fund an expansion of an existing back-end semiconductor assembly and test facility in Kuala Lumpur, Malaysia, and the loan is guaranteed by the parent company and two indirect subsidiaries.
Facility size: $250.0 million unsecured senior loan from European Investment Bank, signed September 1, 2026
Use of proceeds: expansion of an existing assembly and test facility in Kuala Lumpur, Malaysia
Borrowings may be in U.S. dollars or euros, at fixed or floating rates, with a maximum tenor of six years
A potential second facility agreement may be entered into in due course
Presidio Property Trust began an exchange offer for all outstanding shares of its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock, with each tendered share receiving 5.5 shares of Series A Common Stock. The offer expires October 2, 2026, unless extended or terminated, and the filing says the Board approved it but makes no recommendation to holders on whether to participate. Shareholders should note that the exchange would change the company's capital structure by converting preferred holdings into common shares.
As of September 2, 2026, 973,736 shares of Series D Preferred Stock were outstanding.
Each validly tendered Series D share receives 5.5 shares of Common Stock.
The offer expires at 11:59 p.m. New York City time on October 2, 2026, unless extended or terminated early.
Certain directors and executive officers have indicated they intend to tender their shares, on the same terms as other holders; the offer is not contingent on a minimum tender.
TOMI Environmental Solutions reported that holders converted convertible notes with an aggregate principal amount of $2,475,000 into 1,649,989 shares of common stock as of September 1, 2026. As a result, shareholders' equity is approximately $3.8 million, above the $2.5 million Nasdaq requirement, but the company says there is no assurance the Nasdaq Hearings Panel will deem it compliant.
Convertible notes with $2,475,000 aggregate principal converted into common stock as of September 1, 2026
Company issued 1,649,989 shares of common stock upon conversion
Shareholders' equity of approximately $3.8 million exceeds the $2.5 million requirement under Nasdaq Listing Rule 5550(b)(1)
Company states there can be no assurances the Nasdaq Hearings Panel will deem it to have regained compliance
MediciNova notified Yorkville on August 31, 2026 that it is terminating the Standby Equity Purchase Agreement dated July 30, 2025, with termination effective September 8, 2026. Under the agreement, the company could have sold up to $30.0 million of its common stock, but it sold only 175,000 shares for $0.2 million, and no borrowings or fees are outstanding.
Standby Equity Purchase Agreement with Yorkville dated July 30, 2025; termination notice delivered August 31, 2026, effective September 8, 2026
Agreement allowed sales of up to $30.0 million of common stock; company sold 175,000 shares at $1.39 to $1.40 per share for $0.2 million
No outstanding borrowings, advance notices or shares to be issued, and no termination fees owed by either party
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.